Drug Shortage Report for APO-MEMANTINE

Last updated on 2020-06-03 History
Report ID 14191
Drug Identification Number 02366487
Brand name APO-MEMANTINE
Common or Proper name MEMANTINE
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) MEMANTINE HYDROCHLORIDE
Strength(s) 10MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL
ATC code N06DX
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-08-31
Actual start date 2017-08-18
Estimated end date 2020-06-05
Actual end date 2020-05-29
Shortage status Resolved
Updated date 2020-06-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v28 2020-06-03 French Compare
v27 2020-06-03 English Compare
v26 2020-04-27 French Compare
v25 2020-04-27 English Compare
v24 2020-03-30 French Compare
v23 2020-03-30 English Compare
v22 2020-03-30 English Compare
v21 2018-09-10 French Compare
v20 2018-09-10 English Compare
v19 2018-08-27 French Compare
v18 2018-08-27 English Compare
v17 2018-05-01 French Compare
v16 2018-05-01 English Compare
v15 2017-11-15 French Compare
v14 2017-11-15 English Compare
v13 2017-11-07 French Compare
v12 2017-11-07 English Compare
v11 2017-10-31 French Compare
v10 2017-10-31 English Compare
v9 2017-10-16 French Compare

Showing 1 to 20 of 28